ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pain"

  • Abstract Number: 1651 • ACR Convergence 2020

    Efficacy and Safety of Multiple Intra-articular Corticosteroid Injections for Osteoarthritis – a Systematic Review and Meta-analysis of Randomised Controlled Trials and Observational Studies

    Shazeen Ayub1, Jaspreet Kaur1, Michelle Hui2, Michelle Hall1, Michael Doherty3 and Weiya Zhang1, 1Academic Rheumatology, School of Medicine, University of Nottingham, UK, Nottingham, United Kingdom, 2Royal Derby Hospital, Derby, UK, Derby, United Kingdom, 3Academic Rheumatology, School of Medicine, University of Nottingham, UK, Nottingham, England, United Kingdom

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis worldwide and is becoming more prevalent with the increasing age of the population.  As Intra-articular…
  • Abstract Number: 0027 • ACR Convergence 2020

    CYP2D6 Genotype and Reduced Codeine Analgesic Effect in Real-World Clinical Practice

    Daniel Carranza Leon1, Alyson Dickson2, Andrea Gaedigk3, C. Michael Stein2 and Cecilia Chung2, 1Vanderbilt University Medical Center, Nashville, TN, 2Vanderbilt University Medical Center, Nashville, 3University of Missouri, Kansas City

    Background/Purpose: Codeine, a widely prescribed analgesic, is an inactive pro-drug that is metabolized to morphine, the active drug, by cytochrome P450 2D6 (CYP2D6), a highly…
  • Abstract Number: 0551 • ACR Convergence 2020

    Physical Performance as a Mediator of the Association Between Depression and Pain in Knee Osteoarthritis

    Alan Rathbun1, Elizabeth Stuart2, Michelle Shardell1, Trang Nguyen2, Alice Ryan1, Joseph Gallo2, Michelle Yau3, Megan Schuler4 and Marc Hochberg1, 1University of Maryland School of Medicine, Baltimore, MD, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 3Hinda and Arthur Marcus Institute for Aging Research, Boston, MA, 4RAND Corporation, Boston, MA

    Background/Purpose: Depression is common in knee osteoarthritis (OA), and leads to reduced physical function, which may mediate the effect of depression on pain. However, research…
  • Abstract Number: 1030 • ACR Convergence 2020

    Pain Medication Use Among Ankylosing Spondylitis and Psoriatic Arthritis Patients Before and After Initiation of Biologic Therapy

    Theresa Hunter1, Chi Nguyen2, Julie Birt3, Joseph Smith2, Mingyang Shan3, Hiangkiat Tan2, Jeffrey Lisse3 and Keith Isenberg4, 1Eli Lilly and Company, Indianapolis, 2Healthcore, Inc, Wilmington, DE, 3Eli Lilly and Company, Indianapolis, IN, 4Anthem, Inc, Indianapolis, IN

    Background/Purpose: Pain is a common symptom among ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients and can be debilitating, making pain management an integral part…
  • Abstract Number: 1321 • ACR Convergence 2020

    Central Sensitization, Disease Perception and Obesity Should Be Taken into Account When Interpreting Disease Activity in Patients with Axial Spondyloarthritis

    Stan Kieskamp1, Davy Paap2, Marllies Carbo1, Freke Wink3, Reinhard Bos4, Hendrika Bootsma1, Suzanne Arends5 and Anneke Spoorenberg5, 1University Medical Centre Groningen, Groningen, Netherlands, 2, Department of Rehabilitation Medicine, University of Medical Centre Groningen, Groningen, Netherlands, 3Medical Centre Leeuwarden, Leeuwarden, Netherlands, 4Medical Centre Leeuwarden, Leeuwarden, 5University Medical Centre Groningen and Medical centre Leeuwarden, Groningen, Netherlands

    Background/Purpose: Up to 40% of ankylosing spondylitis patients report persistently high pain scores of >4 (scale of 0-10) even after responding to long-term TNF-α blocking…
  • Abstract Number: 1655 • ACR Convergence 2020

    Pain Reduction Post Total Knee Replacement in Opioid Users and Non-users

    Lindsey MacFarlane1, Yinzhu Jin1, Yvonne Lee2, Joyce Lii3, Jeffrey Katz4, Patricia Franklin5 and Seoyoung Kim1, 1Brigham and Women's Hospital, Boston, MA, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Brigham and Women's Hospital, Boston, 4Harvard Medical School / The Orthopaedic and Arthritis Center for Outcomes Research (OrACORe) at Brigham and Women's Hospital, Boston, MA, 5Northwestern University, Chicago

    Background/Purpose: End-stage knee osteoarthritis (OA) is often managed with opioids and total knee replacement (TKR). Studies ascertaining opioid use via record review are conflicting as…
  • Abstract Number: 0028 • ACR Convergence 2020

    Pain in the Time of Corona: Impact of COVID 19 Outbreak on Fibromyalgia Patients

    Valerie Aloush1, Avital Gurfinkel2, Noam Shachar3, Jacob Ablin1 and Odelia Elkana4, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Academic College TelAviv- Jaffa, Tel Aviv, Israel, 3Acamedic College Tel Aviv- Jaffa, Tel Aviv, Israel, 4Academic College Tel Aviv Jaffa, Tel Aviv, Israel

    Background/Purpose: Fibromyalgia is a chronic pain disorder, characterized by abnormal pain processing in the central nervous system. Acute or chronic stress may trigger or aggravate…
  • Abstract Number: 0563 • ACR Convergence 2020

    Relation of Pain Sensitization to Isokinetic Knee Extension Torque: The MOST Study

    Patrick Corrigan1, Tuhina Neogi2, Laura Frey Law3, Neil Segal4, Michael Nevitt5, Beth Lewis6 and Joshua Stefanik1, 1Northeastern University, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3University of Iowa, Iowa City, IA, 4University of Kansas Medical Center, Iowa City, IA, 5Department of Epidemiology and Biostatistics, University of California San Francisco, Orinda, CA, 6University of Alabama at Birmingham, Birmingham

    Background/Purpose: Central and local alterations in nociception are related to heightened pain severity and can be present in people who have knee osteoarthritis (OA). Yet,…
  • Abstract Number: 1085 • ACR Convergence 2020

    Pain in Myositis Is Associated with the Disease Activity

    Anjana Chandrasekhara Pillai1, Chester Oddis2, Siamak Moghadam-Kia3, Dana Ascherman4, Nicole Neiman5, Diane Koontz5, Ren Dianxu5 and Rohit Aggarwal4, 1UPMC Mckeesport, Pittsburgh, PA, 2Department of Medicine, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, 3University of Pittsburgh Medical Center, Pittsburgh, PA, 4University of Pittsburgh, Pittsburgh, PA, 5UPMC, Pittsburgh, PA

    Background/Purpose: Pain in myositis is poorly studied and multifactorial relating to muscle weakness, arthritis, myofasciitis, fibromyalgia or other co-morbidities. We sought to prospectively evaluate patient-reported…
  • Abstract Number: 1459 • ACR Convergence 2020

    The Association of Frequent Knee Bending with Trajectories of Pain and Physical Function over 8 Years in Knee Osteoarthritis

    Jason Jakiela1, Dana Voinier1, Thomas Bye1, Maria Tukis1, Kiely Konyak1, Dylan Orloff1 and Daniel White1, 1University of Delaware, Newark, DE

    Background/Purpose: Frequent bending increases loading at the knee and is a risk factor for worsening knee pain associated with knee osteoarthritis (OA). Knee bending is…
  • Abstract Number: 1657 • ACR Convergence 2020

    Do Comorbidities Limit Improvement in Pain and Physical Function After Total Knee Arthroplasty in Patients with Knee Osteoarthritis?

    Lauren King1, Esther Waugh1, Allyson Jones2, Deborah Marshall3 and Gillian Hawker4, 1University of Toronto, Toronto, Canada, 2University of Alberta, Edmonton, AB, Canada, 3University of Calgary, Calgary, AB, Canada, 4University of Toronto, Toronto, ON, Canada

    Background/Purpose: Individuals with knee osteoarthritis (OA) are increasingly living with multiple comorbid conditions. The presence of comorbidities has been associated with having worse OA symptoms…
  • Abstract Number: 0061 • ACR Convergence 2020

    Rheumatologists’ Attitudes Toward Palliative Care and Medical Assistance in Dying

    Alexandra Saltman1, Caroline McGuinty2, Gursimran Chandhoke3, Simon Oczkowski4, Heather McDonald-Blumer1, Ebru Kaya5 and Kirsten Wentlandt6, 1University Health Network and Sinai Health System, University of Toronto Faculty of Medicine, Toronto, ON, Canada, 2Ottawa Heart Institute and University of Ottawa, Ottawa, ON, Canada, 3Lakeridge Health, Oshawa, ON, Canada, 4Juravinski Hospital and McMaster University, Hamilton, ON, Canada, 5University Health Network,, University of Toronto Faculty of Medicine, Toronto, ON, Canada, 6University Health Network, University of Toronto Faculty of Medicine, Toronto, ON, Canada

    Background/Purpose: Despite major advances in the treatment of systemic rheumatic diseases, a population remains—including those with systemic vasculitis, inflammatory myositis and systemic sclerosis—who suffer from…
  • Abstract Number: 0564 • ACR Convergence 2020

    Incidence and Progression of Foot Osteoarthritis

    Rami Eltaraboulsi1, Amanda Nelson2, Carolina Alvarez3, Jordan Renner4, Catherine Bowen5, Lucy Gates5 and Yvonne Golightly6, 1University of North Carolina at Chapel Hill, Apex, NC, 2University of North Carolina at Chapel Hill Thurston Arthritis Research Center, Chapel Hill, NC, 3University of North Carolina at Chapel Hill Thurston Arthritis Research Center, Miami, FL, 4University of North Carolina, Chapel Hill, NC, 5University of Southampton, Southampton, United Kingdom, 6University of North Carolina at Chapel Hill Dept of Epidemiology, Chapel Hill, NC

    Background/Purpose: Foot osteoarthritis (OA) is a common cause of disability in older adults yet remains an understudied area. The purpose of this study was to…
  • Abstract Number: 1101 • ACR Convergence 2020

    Effect of Transcutaneous Vagal Nerve Stimulation in Erosive Hand Osteoarthritis: Results from an Open-label Non-randomized Pilot Trial

    Alice Courties1, Camille Deprouw2, Emmanuel Maheu3, Eric Gibert4, Jacques-Eric Gottenberg5, Julien Champey6, Béatrice Banneville7, Camille Chesnel8, Gerard Amarenco8, Alexandra Rousseau9, Francis Berenbaum1 and Jeremie Sellam1, 1AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Centre de Recherche Saint-Antoine, INSERM UMR_S 938,Sorbonne Université, Paris, 75012, France, Paris, France, 21. AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Paris, 75012, France, Paris, France, 3AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Paris, 75012, Paris, France, 4Cabinet de Rhumatologie, 94200 Ivry sur Seine, Paris, France, 5Service de Rhumatologie, Centre national de référence pour les maladies auto-immunes systémiques, Hôpital universitaire de Strasbourg, Université de Strasbourg, Strasbourg,, Strasbourg, France, 6AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Paris, 75012,, paris, France, 7AP-HP, Hôpital Pitié-Salpêtrière, Service de Rhumatologie, Paris, 75013, Paris, France, 8Sorbonne Université, GRC 001, GREEN Groupe de Recherche Clinique en Neuro-Urologie, AP-HP, Hôpital Tenon, F-75020 Paris,, Paris, France, 9AP-HP, Hôpital Saint-Antoine, Unité de Recherche Clinique de l'Est Parisien (URC-Est), Paris, 75012,, Paris, France

    Background/Purpose: Beyond classical effect on vegetative functions, the activation of the vagus nerve inhibits inflammation and reduces the pain signal. Vagus nerve stimulation (VNS) can…
  • Abstract Number: 1482 • ACR Convergence 2020

    Joint Safety with Tanezumab: Integrated Analyses from Randomized Controlled Phase 3 Studies in Patients with Osteoarthritis

    John Carrino1, Timothy McAlindon2, Eric Vignon3, Mark Brown4, Aimee Burr4, Robert Fountaine4, Glenn Pixton5, Lars Viktrup6, Christine West7 and Kenneth Verburg8, 1Hospital for Special Surgery, Hackensack, NJ, 2Tufts Medical Center, Boston, MA, 3Université Claude Bernard Lyon 1, Pierre Benite, France, 4Pfizer Inc., Groton, CT, 5Pfizer Inc., Morrisville, NC, 6Eli Lilly and Company, Indianapolis, IN, 7Pfizer Inc, Groton, CT, 8Pfizer Inc, Groton

    Background/Purpose: Tanezumab, a monoclonal antibody that inhibits nerve growth factor, has been shown effective in the management of osteoarthritis (OA) pain.1,2 Due to the potential…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 37
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology